Experimental and theoretical advances in functional understanding of flavonoids as anti-tumor agents

Bandarugattu V Babu1, Naveen K Konduru, Waro Nakanishi

  • 1Department of Chemistry, Indian Institute of Technology Roorkee, Roorkee 247667, India.

Insights

Flavonoids show anti-tumor potential by acting as antioxidants at various cancer stages. Understanding their structure-activity relationships can enhance their effectiveness against cancer and inflammation.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Flavonoids are recognized for anti-tumor potential, but their mechanisms and structure-function relationships are not fully understood.
  • Flavonoids exert effects at multiple stages of cancer progression.
  • Their antioxidant and pro-oxidant behaviors are critical to their biological activity.

Purpose of the Study:

  • To review the pro-oxidant and antioxidant behavior of diverse flavonoid classes.
  • To explore structure-activity relationships for enhanced anti-cancer and anti-inflammatory functions.
  • To discuss clinical data and structural basis for improving flavonoid efficacy.

Main Methods:

  • Review of literature on flavonoid structure, antioxidant activity, and cancer mechanisms.
  • Analysis of structure-function relationships across different flavonoid subclasses (chalcones, flavones, isoflavones, flavanols, flavanones, anthocyanins).
  • Examination of in vitro, in vivo, and cell system data.

Main Results:

  • Flavonoids exhibit distinct structure-function relationships influencing their anti-cancer effects.
  • Their pro-oxidant and antioxidant activities are context-dependent and crucial for therapeutic action.
  • Specific structural features can be optimized to enhance antioxidant capacity.

Conclusions:

  • Flavonoids possess significant potential as anti-tumor and anti-inflammatory agents.
  • Optimizing flavonoid structures based on antioxidant activity is key to improving their clinical benefits.
  • Further research into structure-activity relationships will advance their application in cancer therapy.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...